Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE
- PMLiVE

Pharmaceutical Market Europe – January 2020

Can marketing change the world?Happy New Year! And welcome to a new decade, which promises to deliver more innovation, research breakthroughs and disruption to healthcare than ever before.Our cover story...

- PMLiVE

Pharmaceutical Market Europe – December 2019

Sparking the imagination! It’s Christmas, and all around people are scurrying to decorate their homes and buy that perfect present for that special someone. The big stores have released their...

- PMLiVE

Pharmaceutical Market Europe – November 2019

Patience and persistenceWelcome to the November issue of PME. In our cover article, Chris Ross explores why pharma’s multichannel maturity isn’t just about hard technology. Looking at the Across Health...

- PMLiVE

Pharmaceutical Market Europe – October 2019

Why yesterday’s thinking won’t solve tomorrow’s problemsWelcome to the October issue of PME. In our cover article, Chris Ross looks at why creative partnerships could be key to commercial success...

- PMLiVE

Pharmaceutical Market Europe – September 2019

Patient vs Pharma, this is the situation which the industry dreads, but in 2019 has become a reality on several fronts: when patients see pharma not as a friend, but...

- PMLiVE

Pharmaceutical Market Europe – July/August 2019

Patient vs Pharma, this is the situation which the industry dreads, but in 2019 has become a reality on several fronts: when patients see pharma not as a friend, but...

- PMLiVE

Pharmaceutical Market Europe – June 2019

Our cover star this month is a plucky little bronze statue called Fearless Girl. She originally took up her defiant pose outside the New York Stock Exchange, but can currently...

- PMLiVE

Pharmaceutical Market Europe – May 2019

We are currently just at the beginning of the cell and gene therapy revolution, one which promises to cure previously untreatable diseases – and all with a single treatment.

- PMLiVE

Pharmaceutical Market Europe – April 2019

The long-running row between Vertex and NHS England and NICE over Orkambi has been a low point in the world of UK market access

- PMLiVE

Pharmaceutical Market Europe – March 2019

The EMA’s departure is a tragedy for the UK – but we’re heading for a bigger one

- PMLiVE

Pharmaceutical Market Europe – February 2019

The very idea of being able to edit our genes still sounds like something from science fiction, but in 2019, it is now very much a scientific reality.

- PMLiVE

Pharmaceutical Market Europe – January 2019

Just a few years into the New Year, the $74bn acquisition of Celgene by BMS has woken us all up from our post-festive slump with a bang. The merger is...